Skip to main content
LIVN
NASDAQ Industrial Applications And Services

LivaNova Tops Q3 Revenue Estimates and Lifts Full-Year 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$79.9
Mkt Cap
$4.402B
52W Low
$48.82
52W High
$85.76
52W Position info
64% above low
Off High info
6.8% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

LIVN sits 64% above its 52-week low of $48.82.

Summary

LivaNova posted Q3 revenue of $393.1M (+9.9%) and adjusted diluted EPS of $1.23, then raised full-year 2026 revenue growth guidance to 9%-10% and adjusted EPS to $4.40-$4.50.


Key Events · Earnings and Guidance · LIVN

  • Q3 Revenue Grows 9.9% to $393.1M

    Cardiopulmonary revenue rose 10.9% to $225.3M and Neuromodulation 11.1% to $166.1M, with growth across all regions.

  • Full-Year Guidance Raised on Both Lines

    Constant-currency revenue growth guidance lifted to 9%-10% from 8%-9%, and adjusted diluted EPS to $4.40-$4.50 from $4.30-$4.40, a $0.10 midpoint increase.

  • GAAP EPS Falls on Litigation and Derivative Items

    GAAP diluted EPS was $0.11 versus $0.49 a year ago, reflecting $34.0M of other operating expense and a $28.2M fair-value gain on the 2029 Notes conversion option deducted from the diluted numerator; adjusted diluted EPS rose to $1.23 from $1.11.

  • Cash Generation Holds at $55.8M Adjusted FCF

    Q3 operating cash flow was $73.7M and adjusted free cash flow $55.8M; the full-year adjusted free cash flow range of $140M-$160M was maintained.


Analysis · LIVN · Industrial Applications And Services

The guidance raise is the headline here, not the top-line beat. LivaNova grew Q3 revenue 9.9% to $393.1M and lifted full-year 2026 guidance on both lines: constant-currency revenue growth to 9%-10% from 8%-9%, and adjusted diluted EPS to $4.40-$4.50 from $4.30-$4.40. Adjusted EPS of $1.23 rose from $1.11 a year ago, while GAAP diluted EPS fell to $0.11 from $0.49. That decline reflects a $28.2M gain on the 2029 Notes conversion option change in fair value deducted from the diluted numerator, plus $34.0M of other operating expense tied largely to the 3T Heater-Cooler litigation provision. By resetting the earnings base for the year, the raise carries more weight than the quarter itself, and it comes with a maintained $140M-$160M adjusted free cash flow range.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LIVN was trading at $79.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $48.82 to $85.76. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LIVN - Latest Insights

LIVN
Nov 04, 2026, 3:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $96.42
Real-time Price: $92.91 info
Change: -$3.51 (-4%) info
Market Cap: $5.12B info
LIVN
Nov 04, 2026, 6:02 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $79.90
Real-time Price: $92.91 info
Change: +$13.01 (+16%) info
Market Cap: $5.12B info
LIVN
Aug 06, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $78.15
Real-time Price: $92.91 info
Change: +$14.77 (+19%) info
Market Cap: $5.12B info
LIVN
Aug 05, 2026, 2:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $76.37
Real-time Price: $92.91 info
Change: +$16.54 (+22%) info
Market Cap: $5.12B info
LIVN
Aug 05, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $87.49
Real-time Price: $92.91 info
Change: +$5.42 (+6%) info
Market Cap: $5.12B info